Johnson & Johnson (JNJ) Financials

JNJ Assets vs Liabilities

DateAssetsLiabilities
March 31, 2024 ? ?
Dec. 31, 2023 167.6 billion 98.8 billion
Sept. 30, 2023 166.1 billion 94.8 billion
June 30, 2023 191.7 billion 115.3 billion

JNJ Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 ? ?
Dec. 31, 2023 6.3 billion 178.0 million
Sept. 30, 2023 6.5 billion 296.0 million
June 30, 2023 3.1 billion 382.0 million

JNJ Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
March 31, 2024 ?
Dec. 31, 2023 4.1 billion
Sept. 30, 2023 26.0 billion
June 30, 2023 5.1 billion

JNJ Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
March 31, 2024 - - -
Dec. 31, 2023 22.9 billion - -
Sept. 30, 2023 23.5 billion 26.1 billion -
June 30, 2023 28.5 billion 33.9 billion -

JNJ Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
March 31, 2024 2.4 billion
Dec. 31, 2023 2.4 billion
Sept. 30, 2023 2.5 billion
June 30, 2023 2.6 billion

JNJ Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
March 31, 2024 - 3.5 billion - -
Dec. 31, 2023 1.6 billion 4.5 billion 5.8 billion -
Sept. 30, 2023 967.0 million 3.4 billion 5.4 billion -
June 30, 2023 1.1 billion 3.8 billion 6.7 billion -

JNJ Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
March 31, 2024 21.4 billion 5.4 billion
Dec. 31, 2023 21.4 billion 7.0 billion
Sept. 30, 2023 21.3 billion 6.5 billion
June 30, 2023 25.5 billion 8.2 billion

JNJ

List: Champions

Price: $148.75

52 week price:
143.13
175.97

Dividend Yield: 0.03%

5-year range yield:
0.03%
3.35%

Forward Dividend Yield: 3.33%

Payout Ratio: 73.70%

Payout Ratio Range:
40.69%
589.80%

Dividend Per Share: 4.96 USD

Earnings Per Share: 6.72 USD

P/E Ratio: 21.66

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 6.9 million

Ebitda: 2.9 billion

Market Capitalization: 350.3 billion

Average Dividend Frequency: 4

Years Paying Dividends: 63

DGR3: 5.32%

DGR5: 5.43%

DGR10: 5.72%

DGR20: 7.64%

Links: